Aegis Lifesciences happy to share their presence at Hospitalar 2022

  Percutaneous nephrolithotomy (PCNL) is considered the gold-standard treatment for large and complex kidney stones and remains the treatment of choice for renal stones > 2 cm. As the incidence of urolithiasis continues to rise globally, PCNL plays a vital role in achieving complete stone clearance.1,2 Despite continuous advancements in surgical techniques and equipment, intraoperative bleeding is still one of the most challenging aspects of the procedure. In tubeless PCNL, effective bleeding control is crucial. Removing the nephrostomy tube can improve patient comfort and speed recovery, but it also increases the need for reliable haemostasis at the nephrostomy tract. To address this challenge, surgeons are increasingly turning to adjunctive haemostatic agents, including flowable gelatin-based matrices such as FLOGEL® . In this blog, we explore how FLOGEL® is used in tubeless PCNL, along with its haemostatic performance and reported clinical outcomes. Press enter or click to v...

  Effective bleeding control is essential for successful dental and oral surgical procedures, including tooth extractions, periodontal surgery, implant placement, tissue biopsies, gingival soft tissue procedures, and other exodontic interventions. 1–3 Uncontrolled bleeding can reduce visibility, prolong procedure time, and delay healing. While conventional methods like pressure and suturing remain fundamental, absorbable haemostatic agents provide important additional support when rapid haemostasis is required.1,2 Among these, absorbable gelatin sponges (AGS) such as SURGISPON® DENTAL are widely used to aid clot formation and control bleeding. Their porous structure enables efficient blood absorption, supports stable clot development, and offers high biocompatibility for safe use in surgical sites. The AGS has shown the superior ability of blood absorption compared to sterile gauze, making them a reliable option for postoperative bleeding management in dental procedures.2 This blo...